They usually resolve within days to weeks without treatment
Carnitine Synergy Designs for Health $N/A (MSRP) Create account for pricing Already have an account
Research has shown that MT-2 can reduce food intake and potentially influence energy expenditure and fat oxidation
FDA approval of DESMODA, the first oral liquid formulation of desmopressin
The Health Concerns By 2023, patients and doctors began reporting: Gastroparesis (stomach paralysis) Gallbladder disease (sometimes requiring surgery) Severe nausea, vomiting, and diarrhea Intestinal blockages A rare eye condition: NAION (a type of optic nerve damage) In response, the FDA updated the drugs warning labels to list risks like gallbladder disease, abdominal pain, constipation, diarrhea, nausea, and vomiting